Gastric cancer in humans arises in the setting of oxyntic atrophy (parietal cell loss) and attendant hyperplastic and metaplastic lineage changes within the gastric mucosa. Helicobacter infection in mice and humans leads to spasmolytic polypeptide-expressing metaplasia (SPEM). In a number of mouse models, SPEM arises after oxyntic atrophy. In mice treated with the parietal cell toxic protonophore DMP-777, SPEM appears to arise from the transdifferentiation of chief cells. These results support the concept that intrinsic mucosal influences regulate and modulate the appearance of gastric metaplasia even in the absence of significant inflammation, whereas chronic inflammation is required for the further neoplastic transition. gastric adenocarc...
Gastric cancer remains a prominent player in worldwide cancer mortality, due to its poor detection a...
Gastric cancer remains a prominent player in worldwide cancer mortality, due to its poor detection a...
Proton pump inhibitor use is associated with an increased risk of gastric cancer, which may be media...
Gastric carcinogenesis involves the loss of parietal cells (oxyntic atrophy) and subsequent replacem...
The development of intestinal-type gastric cancer is preceded by loss of parietal cells (oxyntic atr...
Intestinal-type gastric adenocarcinoma evolves in a field of pre-existing metaplasia. Over the past ...
BACKGROUND & AIMS: The loss of parietal cells from the fundic mucosa leads to the emergence of metap...
OBJECTIVES: Spasmolytic polypeptide-expressing metaplasia (SPEM) develops as a preneoplastic lesion ...
OBJECTIVE: Metaplastic lineages in the oxyntic mucosa of the stomach are critical preneoplastic prec...
BACKGROUND & AIMS: The loss of parietal cells from the gastric mucosa (oxyntic atrophy) is a critica...
Objectives: Spasmolytic polypeptide-expressing metaplasia (SPEM) develops as a preneoplastic lesion ...
This review concerns stem cells and their relation to intestinal metaplasia. When gastric regions of...
This review concerns stem cells and their relation to intestinal metaplasia. When gastric regions of...
This review concerns stem cells and their relation to intestinal metaplasia. When gastric regions of...
This review concerns stem cells and their relation to intestinal metaplasia. When gastric regions of...
Gastric cancer remains a prominent player in worldwide cancer mortality, due to its poor detection a...
Gastric cancer remains a prominent player in worldwide cancer mortality, due to its poor detection a...
Proton pump inhibitor use is associated with an increased risk of gastric cancer, which may be media...
Gastric carcinogenesis involves the loss of parietal cells (oxyntic atrophy) and subsequent replacem...
The development of intestinal-type gastric cancer is preceded by loss of parietal cells (oxyntic atr...
Intestinal-type gastric adenocarcinoma evolves in a field of pre-existing metaplasia. Over the past ...
BACKGROUND & AIMS: The loss of parietal cells from the fundic mucosa leads to the emergence of metap...
OBJECTIVES: Spasmolytic polypeptide-expressing metaplasia (SPEM) develops as a preneoplastic lesion ...
OBJECTIVE: Metaplastic lineages in the oxyntic mucosa of the stomach are critical preneoplastic prec...
BACKGROUND & AIMS: The loss of parietal cells from the gastric mucosa (oxyntic atrophy) is a critica...
Objectives: Spasmolytic polypeptide-expressing metaplasia (SPEM) develops as a preneoplastic lesion ...
This review concerns stem cells and their relation to intestinal metaplasia. When gastric regions of...
This review concerns stem cells and their relation to intestinal metaplasia. When gastric regions of...
This review concerns stem cells and their relation to intestinal metaplasia. When gastric regions of...
This review concerns stem cells and their relation to intestinal metaplasia. When gastric regions of...
Gastric cancer remains a prominent player in worldwide cancer mortality, due to its poor detection a...
Gastric cancer remains a prominent player in worldwide cancer mortality, due to its poor detection a...
Proton pump inhibitor use is associated with an increased risk of gastric cancer, which may be media...